サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1781350

関節痛の注射の世界市場

Joint Pain Injections

出版日
ページ情報
英文 378 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.17円
関節痛の注射の世界市場
出版日: 2025年08月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 378 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

関節痛の注射の世界市場は2030年までに55億米ドルに達する

2024年に38億米ドルと推定される関節痛の注射の世界市場は、2024～2030年の分析期間にCAGR 6.7%で成長し、2030年には55億米ドルに達すると予測されます。本レポートで分析したセグメントの一つであるヒアルロン酸注射は、CAGR6.3%を記録し、分析期間終了時には34億米ドルに達すると予測されます。副腎皮質ステロイド注射セグメントの成長率は、分析期間中CAGR 7.6%と推定されます。

米国市場は10億米ドルと推定、中国はCAGR 10.4％で成長予測

米国の関節痛の注射市場は2024年に10億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに11億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは10.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.3％と6.4％と予測されています。欧州では、ドイツがCAGR 4.4%で成長すると予測されています。

世界の関節痛の注射市場- 主要動向と促進要因まとめ

関節痛の注射市場は、関節炎、変形性関節症、その他の筋骨格系障害の有病率の上昇により、著しい成長を遂げています。世界人口の高齢化とライフスタイルに関連した関節問題の増加により、効果的で低侵襲な疼痛管理ソリューションへの需要が急増しています。副腎皮質ステロイド、ヒアルロン酸、多血小板血漿（PRP）、幹細胞を用いた治療法などの関節痛の注射は、痛みを和らげ、可動性を改善し、人工関節置換術などの外科的介入を遅らせるために広く使用されています。生物製剤、精密医療、再生療法の進歩は、関節疼痛管理をより効果的で個別化されたものにし、市場をさらに変えつつあります。

関節痛の注射市場を形成する新たな動向とは？

関節痛の注射市場で最も注目すべき動向の1つは、再生医療、特に多血小板血漿（PRP）や幹細胞ベースの注射に対する嗜好の高まりです。患者自身の血液に由来するPRP療法は、変形性関節症やスポーツ外傷の組織治癒を促進し、炎症を抑えるために使用されることが多くなっています。同様に、幹細胞、特に間葉系幹細胞（MSC）の注射は、軟骨を再生し、病気の進行を遅らせる能力があるとして研究されています。患者が副腎皮質ステロイドやヒアルロン酸に代わるものを求める中、進行中の臨床試験や研究の進歩に支えられ、再生療法の採用は拡大すると予想されます。

もう一つの重要な動向は、関節疼痛管理における個別化医療の台頭です。遺伝子検査、バイオマーカー分析、画像技術の進歩により、医師は個々の患者プロファイルに合わせた注射治療を行えるようになっています。個別化された治療計画は、関節変性の重症度、炎症反応、患者の全体的な健康状態に基づいて最適な注射の種類を特定することで、有効性を向上させ、副作用を減らし、転帰を最適化します。このような精密医療へのシフトは、患者の満足度を高め、関節痛の注射と並ぶ高度な診断ツールの需要を促進しています。

また、低侵襲技術や画像誘導注射手技も人気を集めています。正確な注射針の位置決めに超音波や透視を使用することで、関節注射の精度と効果が向上し、痛みが軽減され、合併症が最小限に抑えられています。画像誘導注射は、従来の盲目的な注射では効果が薄かった股関節や脊椎のような深部の関節に特に有効です。技術の進歩に伴い、より多くのクリニックや病院がガイド付き注射を採用するようになり、患者の転帰が改善され、市場の需要も高まっています。

技術進歩はどのように市場を牽引しているのか？

技術革新は、治療の有効性、安全性、持続性を高めることにより、関節痛の注射市場に革命をもたらしています。最も重要な進歩の一つは、次世代関節内補充療法の開発です。従来のヒアルロン酸注射は、関節を潤滑にすることで一時的な緩和をもたらすが、架橋ヒアルロン酸を用いた新しい製剤は、より長期の効果と改善された粘弾性特性を提供します。これらの進歩により、関節内補充療法は人工関節置換術を遅らせたい軽度から中等度の変形性関節症患者にとってより魅力的なものとなりました。

もう一つの画期的な進歩は、放出制御技術を用いた長時間作用型コルチコステロイド注射薬の開発です。従来の副腎皮質ステロイド注射は、迅速な鎮痛効果をもたらすが、効果持続時間が短いです。マイクロスフェアベースの送達システムを用いた新しい製剤は、数ヵ月にわたって持続的な抗炎症効果を発揮するように設計されています。このような技術革新は、頻繁に注射を打たなくても長期の鎮痛効果を必要とする慢性関節痛患者にとって特に有益です。

生物学的製剤や細胞を用いた治療法もまた、関節痛管理において大きな進歩を遂げています。新しい再生アプローチであるエクソソーム療法は、軟骨の損傷を修復し、細胞レベルで炎症を調節する可能性があるとして注目を集めています。PRPや幹細胞とは異なり、エクソソームに基づく注射は無細胞性です。つまり、幹細胞由来の有益なシグナル伝達分子のみを含むため、免疫拒絶反応や副作用のリスクが軽減されます。再生医療の研究が進むにつれて、エクソソーム療法やその他の新規生物製剤は、関節痛の注射市場の主要企業になると予想されます。

関節痛の注射市場の成長の原動力は？

関節痛の注射市場の成長は、変形性関節症や慢性関節障害の有病率の増加、非外科的疼痛管理ソリューションに対する需要の高まり、生物製剤や再生医療の進歩など、いくつかの要因によって牽引されています。高齢者は関節の変性や関節炎にかかりやすいため、世界人口の高齢化は市場拡大に大きく寄与しています。世界保健機関（WHO）によると、変形性関節症は世界の身体障害の主要原因のひとつであり、効果的で長持ちする関節痛治療の必要性を煽っています。

スポーツ医学と整形外科リハビリテーションの役割の拡大も、市場の重要な促進要因です。アスリートや身体活動的な人々は、関節の損傷を頻繁に経験し、早期回復のために低侵襲治療が必要となります。PRP注射やその他の生物学的療法は、治癒を早めダウンタイムを短縮するためにスポーツ医学でますます使用されるようになっており、関節痛の注射の需要拡大に寄与しています。さらに、注射による疼痛管理ソリューションを提供する外来患者や外来ケアセンターの増加により、患者へのアクセスが向上し、市場への浸透が進んでいます。

もう一つの重要な成長要因は、関節痛に対する併用療法が受け入れられつつあることです。PRPとヒアルロン酸、コルチコステロイドと幹細胞治療など、異なる種類の注射を組み合わせて治療効果を高める医師が増えています。このマルチモーダルアプローチは、痛みを即座に和らげるだけでなく、炎症と組織再生の両方に対処することで、長期的な関節の健康をサポートします。併用療法が注目されるにつれ、市場開拓者は臨床研究に投資し、有効性と患者の満足度を最大化する最適な治療プロトコルを開発しています。

効果的で低侵襲な関節痛ソリューションへの需要が高まり続ける中、関節痛の注射市場は大きく成長すると予想されます。再生医療、生物学的治療、個別化された治療アプローチにおける進歩は、業界の将来を形作る上で重要な役割を果たし、患者に手術に代わるより良い選択肢と長期的な疼痛緩和を提供します。

セグメント

注射タイプ（ヒアルロン酸注射、副腎皮質ステロイド注射、多血小板血漿注射）、関節タイプ（膝関節、肩・肘関節、足関節・股関節、その他の関節タイプ）、エンドユーザー（病院、クリニック、その他のエンドユーザー）

調査対象企業の例

  • AbbVie Inc.
  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • Bioventus LLC
  • Chugai Pharmaceutical Co., Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Eli Lilly and Company
  • Emcyte Corporation
  • Ferring Pharmaceuticals
  • Flexion Therapeutics, Inc.
  • Lifecore Biomedical
  • Ono Pharmaceutical Co., Ltd.
  • OrthogenRx, Inc.
  • Pacira BioSciences, Inc.
  • Pfizer Inc.
  • Sanofi
  • SEIKAGAKU CORPORATION
  • Stryker Corporation
  • Teva Pharmaceutical Industries Ltd.
  • Zimmer Biomet Holdings, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP31716

Global Joint Pain Injections Market to Reach US$5.5 Billion by 2030

The global market for Joint Pain Injections estimated at US$3.8 Billion in the year 2024, is expected to reach US$5.5 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Hyaluronic acid injections, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$3.4 Billion by the end of the analysis period. Growth in the Corticosteroid injections segment is estimated at 7.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.0 Billion While China is Forecast to Grow at 10.4% CAGR

The Joint Pain Injections market in the U.S. is estimated at US$1.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 10.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Joint Pain Injections Market - Key Trends & Drivers Summarized

The joint pain injections market is witnessing significant growth due to the rising prevalence of arthritis, osteoarthritis, and other musculoskeletal disorders. With an aging global population and increasing lifestyle-related joint issues, demand for effective, minimally invasive pain management solutions has surged. Joint pain injections, including corticosteroids, hyaluronic acid, platelet-rich plasma (PRP), and stem cell-based therapies, are widely used to alleviate pain, improve mobility, and delay surgical interventions such as joint replacement. Advances in biologics, precision medicine, and regenerative therapies are further transforming the market, making joint pain management more effective and personalized.

What Are the Emerging Trends Shaping the Joint Pain Injections Market?

One of the most notable trends in the joint pain injections market is the growing preference for regenerative medicine, particularly platelet-rich plasma (PRP) and stem cell-based injections. PRP therapy, derived from the patient’s own blood, is increasingly being used to promote tissue healing and reduce inflammation in osteoarthritis and sports injuries. Similarly, stem cell injections, particularly mesenchymal stem cells (MSCs), are being researched for their ability to regenerate cartilage and delay disease progression. As patients seek alternatives to corticosteroids and hyaluronic acid, the adoption of regenerative therapies is expected to grow, supported by ongoing clinical trials and research advancements.

Another significant trend is the rise of personalized medicine in joint pain management. Advances in genetic testing, biomarker analysis, and imaging technologies are enabling physicians to tailor injection treatments to individual patient profiles. Personalized treatment plans improve efficacy, reduce side effects, and optimize outcomes by identifying the most suitable injection type based on the severity of joint degeneration, inflammatory response, and overall patient health. This shift towards precision medicine is enhancing patient satisfaction and driving demand for advanced diagnostic tools alongside joint pain injections.

Minimally invasive techniques and image-guided injection procedures are also gaining traction. The use of ultrasound and fluoroscopy for precise needle placement has improved the accuracy and effectiveness of joint injections, reducing pain and minimizing complications. Image-guided injections are particularly beneficial for deep-seated joints such as the hip and spine, where traditional blind injections may be less effective. As technology advances, more clinics and hospitals are adopting guided injection procedures, leading to improved patient outcomes and higher market demand.

How Are Technological Advancements Driving the Market?

Technological innovations are revolutionizing the joint pain injections market by enhancing the effectiveness, safety, and longevity of treatments. One of the most significant advancements is the development of next-generation viscosupplementation therapies. Traditional hyaluronic acid injections provide temporary relief by lubricating the joint, but newer formulations with cross-linked hyaluronic acid offer longer-lasting effects and improved viscoelastic properties. These advancements have made viscosupplementation more appealing to patients with mild to moderate osteoarthritis who want to delay joint replacement surgery.

Another breakthrough is the development of long-acting corticosteroid injections with controlled-release technology. Traditional corticosteroid injections provide rapid pain relief but have a short duration of effect. Newer formulations with microsphere-based delivery systems are being designed to provide sustained anti-inflammatory benefits over several months. These innovations are particularly beneficial for patients with chronic joint pain who require prolonged relief without frequent injections.

Biologics and cell-based therapies are also making significant strides in joint pain management. Exosome therapy, a novel regenerative approach, is gaining attention for its potential to repair cartilage damage and modulate inflammation at a cellular level. Unlike PRP and stem cells, exosome-based injections are acellular, meaning they contain only the beneficial signaling molecules derived from stem cells, reducing the risk of immune rejection or adverse reactions. As research in regenerative medicine advances, exosome therapy and other novel biologics are expected to become key players in the joint pain injections market.

What Is Driving the Growth of the Joint Pain Injections Market?

The growth in the joint pain injections market is driven by several factors, including the increasing prevalence of osteoarthritis and chronic joint disorders, the rising demand for non-surgical pain management solutions, and advancements in biologics and regenerative medicine. The aging global population is a major contributor to market expansion, as older individuals are more susceptible to joint degeneration and arthritis. According to the World Health Organization (WHO), osteoarthritis is among the leading causes of disability worldwide, fueling the need for effective, long-lasting joint pain treatments.

The expanding role of sports medicine and orthopedic rehabilitation is also a significant market driver. Athletes and physically active individuals frequently experience joint injuries that require minimally invasive treatments for faster recovery. PRP injections and other biologic therapies are increasingly being used in sports medicine to accelerate healing and reduce downtime, contributing to the growing demand for joint pain injections. Additionally, the increasing number of outpatient and ambulatory care centers offering injection-based pain management solutions is improving patient access and market penetration.

Another critical growth driver is the growing acceptance of combination therapies for joint pain. Physicians are increasingly combining different injection types-such as PRP with hyaluronic acid or corticosteroids with stem cell therapy-to enhance treatment outcomes. This multi-modal approach not only provides immediate pain relief but also supports long-term joint health by addressing both inflammation and tissue regeneration. As combination therapies gain traction, market players are investing in clinical research to develop optimized treatment protocols that maximize efficacy and patient satisfaction.

As the demand for effective, minimally invasive joint pain solutions continues to rise, the market for joint pain injections is expected to grow significantly. Advances in regenerative medicine, biologic therapies, and personalized treatment approaches will play a key role in shaping the future of the industry, offering patients better alternatives to surgery and long-term pain relief.

SCOPE OF STUDY:

The report analyzes the Joint Pain Injections market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Injection Type (Hyaluronic acid injections, Corticosteroid injections, Platelet rich plasma injections); Joint Type (Knee, Shoulder & elbow, Ankle & hip, Other joint types); End-Use (Hospitals, Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • AbbVie Inc.
  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • Bioventus LLC
  • Chugai Pharmaceutical Co., Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Eli Lilly and Company
  • Emcyte Corporation
  • Ferring Pharmaceuticals
  • Flexion Therapeutics, Inc.
  • Lifecore Biomedical
  • Ono Pharmaceutical Co., Ltd.
  • OrthogenRx, Inc.
  • Pacira BioSciences, Inc.
  • Pfizer Inc.
  • Sanofi
  • SEIKAGAKU CORPORATION
  • Stryker Corporation
  • Teva Pharmaceutical Industries Ltd.
  • Zimmer Biomet Holdings, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Joint Pain Injections - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Osteoarthritis and Degenerative Joint Conditions Propels Demand for Pain Injections
    • Growing Preference for Minimally Invasive Pain Management Strengthens Business Case for Injectable Therapies
    • Increasing Aging Population Globally Expands Addressable Market for Joint Pain Injections
    • Rapid Adoption of Hyaluronic Acid Injections Spurs Growth in the Knee Osteoarthritis Treatment Segment
    • Expansion of Sports Medicine and Injury Recovery Markets Drives Demand for Corticosteroid Injections
    • Advancements in Regenerative Medicine Accelerate Interest in Platelet-Rich Plasma and Stem Cell Injections
    • Rising Healthcare Expenditure and Insurance Coverage Boost Access to Joint Pain Injection Therapies
    • Physician Preference for In-Office Injectable Solutions Enhances Procedural Volume and Product Demand
    • Increasing Awareness of Early Intervention in Joint Disorders Drives Use of Injections at Earlier Disease Stages
    • Innovation in Long-Acting Formulations Strengthens Value Proposition for Chronic Pain Sufferers
    • Development of Targeted Biologic Injections Expands Therapeutic Options in Inflammatory Joint Diseases
    • Growing Demand for Personalized Pain Management Throws the Spotlight on Customized Injection Protocols
    • Shift Towards Outpatient and Ambulatory Care Settings Spurs Demand for Fast-Acting Injectable Solutions
    • Rise in Orthopedic Clinics and Specialty Pain Management Centers Enhances Distribution and Administration
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Joint Pain Injections Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Joint Pain Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Joint Pain Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Joint Pain Injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hyaluronic acid injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Hyaluronic acid injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Hyaluronic acid injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Corticosteroid injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Corticosteroid injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Corticosteroid injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Platelet rich plasma injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Platelet rich plasma injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Platelet rich plasma injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Knee by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Knee by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Knee by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Shoulder & elbow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Shoulder & elbow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Shoulder & elbow by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Ankle & hip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Ankle & hip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Ankle & hip by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other joint types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other joint types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other joint types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Joint Pain Injections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • JAPAN
    • Joint Pain Injections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • CHINA
    • Joint Pain Injections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • EUROPE
    • Joint Pain Injections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Joint Pain Injections by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Joint Pain Injections by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Joint Pain Injections by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • FRANCE
    • Joint Pain Injections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • GERMANY
    • Joint Pain Injections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Joint Pain Injections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Joint Pain Injections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Joint Pain Injections by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Joint Pain Injections by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Joint Pain Injections by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Joint Pain Injections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • INDIA
    • Joint Pain Injections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Joint Pain Injections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Joint Pain Injections by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Joint Pain Injections by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Joint Pain Injections by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Joint Pain Injections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Joint Pain Injections by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Joint Pain Injections by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Joint Pain Injections by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
  • AFRICA
    • Joint Pain Injections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030

IV. COMPETITION